Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1549986 | 0.87 | ALDH1A1 (0.40) | ALDH1A1HSD17B10TP53RNPEPKDM4E | |
| SCHEMBL20441205 | 0.81 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53RNPEPKDM4E | |
| SCHEMBL13873980 | 0.76 | ALDH1A1 (0.39) | ALDH1A1KDM4E | |
| SCHEMBL12548837 | 0.76 | HDAC3 (0.40) | ALDH1A1HSD17B10RNPEP | |
| SCHEMBL13873968 | 0.75 | — | — | |
| SCHEMBL15627468 | 0.74 | ALDH1A1 (0.32) | ALDH1A1HSD17B10 | |
| SCHEMBL15627465 | 0.74 | HTT (0.36) | ALDH1A1HSD17B10RNPEP | |
| SCHEMBL28512587 | 0.74 | CYP2D6 (0.41) | ALDH1A1HSD17B10RNPEP | |
| SCHEMBL19257459 | 0.73 | — | — | |
| SCHEMBL30934652 | 0.71 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293576-A1 | ANTIVIRAL POLYMERS | THE UNIVERSITY OF MANCHESTER (GB) | 2023-09-21 | — | — | US | disclosed |
| US-11186678-B2 | Radical cascade-enabled synthesis of precision polymers with complex main-chain structures | TRUSTEES OF BOSTON COLLEGE (US) | 2021-11-30 | — | — | US | disclosed |
| US-20200216610-A1 | RADICAL CASCADE-ENABLED SYNTHESIS OF PRECISION POLYMERS WITH COMPLEX MAIN-CHAIN STRUCTURES | TRUSTEES OF BOSTON COLLEGE (US) | 2020-07-09 | — | — | US | disclosed |
| EP-1802726-B1 | PHOTOCHROMIC COMPOUNDS COMPRISING POLYMERIC SUBSTITUENTS AND METHODS FOR PREPARATION AND USE THEREOF | ADVANCED POLYMERIK PTY LTD (AU) | 2011-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293576-A1 | ANTIVIRAL POLYMERS | MAVS, EIF2AK2, ZC3HAV1 | ALDH1A1 3162/4885HSD17B10 3492/4885TP53 1767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.